NK-KIR ligand identification: A quick Q-PCR approach for HLA-C epitope typing

Tissue Antigens

Volumn 69, Issue 4, 2007, Pages 334-337

  Schellekens, J ^a   Rozemuller, E H ^a   Borst, H P E ^a   Otten, H G ^a   Van Den Tweel, J G ^a   Tilanus, M G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

HLA C epitope; KIR; KIR ligand; NK; Q PCR

Indexed keywords

EPITOPE; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; DNA PRIMERS; EPITOPES; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; KILLER CELLS, NATURAL; LIGANDS; POLYMERASE CHAIN REACTION;

EID: 33947608582     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00809.x     Document Type: Article

References (17)

1. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990: 75: 555-62.
2. Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997: 15: 433-44.
3. Barrett AJ, Rezvani K, Solomon S et al. New developments in allotransplant immunology. Hematology 2003: 350-71.
4. Whitelegg A, Barber LD. The structural basis of T-cell allorecognition. Tissue Antigens 2004: 63: 101-8.
5. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002: 295: 2097-100.
6. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005: 5: 201-14.
7. Parham P, McQueen KL. Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat Rev Immunol 2003: 3: 108-22.
8. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002: 20: 217-51.
9. Lanier LL. NK cell recognition. Annu Rev Immunol 2005: 23: 225-74.
10. Biassoni R, Falco M, Cambiaggi A et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995: 182: 605-9.
11. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993: 90: 12000-4.
12. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993: 260: 1121-4.
13. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002: 100: 1935-47.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
15. Dunn PP, Day S, Harvey J, Fuggle SV, Ross J. Identification of an HLA-C variant allele, CW*0805, by sequencing based typing. Tissue Antigens 1998: 52: 587-9.
16. van der Vlies SA, Voorter CE, van den Berg-Loonen EM. A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. Tissue Antigens 1998: 52: 558-68.
17. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001: 62: 1009-30.